Therefore, this indicates that tumor PD-L1 expression positively affects the response to anti-PD-1/PD-L1 therapy and that chemotherapy may drive PD-L1 induction, at least in tumors initially determined as PD-L1 negative. This evidence concerns the gene CD274 and neoplasm.